Merck · 1 hour ago
2026 Future Talent Program - Genome Sciences, Computational Biology - Co-op
Cambridge, MA
Full-time
Onsite
New Grad
$40K/yr - $106K/yrMerck is a leading company in the pharmaceutical industry, and they are seeking students for their Future Talent Program in Genome Sciences and Computational Biology. This co-op opportunity involves working on projects related to cellular and genomic technologies, analysis of sequencing datasets, and developing computational skills.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
Responsibilities
Evaluation of leading edge cellular and genomics technologies including single cell CRISPR-sequencing and spatial transcriptomics
Application of cellular and genomic technologies towards the functional validation of targets and pathways
Analysis of sequencing datasets (e.g. Spatial Transcriptomics) with state-of-the-art methods to better understand disease biology and support target candidate evaluation
Qualification
Required
Candidates must be currently enrolled in a minimum of a Bachelor's degree program in Biological Sciences or a related field of study
Students enrolled in graduate programs (MS or PhD) are highly encouraged to apply
Candidates must be available to work full-time for 6 months in 2026
Candidates must have excellent academic achievement and analytical ability
Candidates must have demonstrated superior communication and interpersonal skills and must be able to work well in a collaborative team environment
Preferred
Candidates should have interest/experience in ANY of the fields of molecular biology, immunology, oncology, cell biology, neuroscience, or bioinformatics
For these computational projects, specific skill sets should include one or more of the following: experience with R or Python programming languages, analysis of bulk or single cell datasets
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Founded in 1891
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Betty Larson
Executive Vice President and Chief Human Resources Officer
Dean Li
Executive Vice President and President, Merck Research Laboratories
Recent News
2026-01-23
2026-01-23
Company data provided by crunchbase